The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Broker snap: ECB stress tests to restore confidence in banks, says Credit Suisse

Thu, 24th Oct 2013 09:44

Creidit Suisse believes that the new round of stress tests by the European Central Bank (ECB) should improve confidence in European banks as it reiterated its 'overweight' position on the sector.The ECB on Wednesday outlined proposals for a year-long series of health checks on European banks, which consists of three main elements; a supervisory risk assessment on liquidity, leverage and funding, an asset quality review (AQR), and a stress test to be conducted in collaboration with the European Banking Authority.The Swiss broker said that the AQR is "broader than we had anticipated" with a very thorough review of various assets being targets. However, the ECB will use the 8% minimum common equity tier-1 ratio as a benchmark "which is more lenient than expectations", it added."At this early stage we reiterate our view that if the ECB review provides transparent enough disclosures on banks' balance sheet this exercise could restore further confidence in the sector."The banking sector in London was trading up 0.76% on Thursday morning, rebounding after a 1.3% fall the day before.BC

Related Shares

More News
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac cause...

22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030 *

21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatm...

21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating seve...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.